HopeStage
Back to all studies
Not recruitingISRCTN12277345

Group body psychotherapy for somatoform disorder - a partly -controlled feasibility study

This study is not recruiting in Germany. It focuses on Somatoform disorder (ICD−10 (F45.x) (compatible with diagnosis of somatic symptom disorder DSM-5 (300.82); Mental and Behavioural Disorders; Somatoform disorder.

Somatic symptom disorders, Somatoform disorder (ICD−10 (F45.x) (compatible with diagnosis of somatic symptom disorder DSM-5 (300.82), ...Other
The study in practice

Understand this study

We have not yet verified a detailed participation summary for this study.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Not recruiting
Enrollment listed in the registry
Not clearly listed
Sponsor
Department of Psychosomatic Medicine and Psychotherapy, Klinikum rechts der Isar,
Sponsor type
Pharmaceutical company
Study type
Other
Intervention type
Other / unclear
Study phase
Not ApplicableFormal phases are mostly used for medication studies and some device studies. Some studies do not use a phase.
Locations
Germany
Age range
Not clearly listed
Official registry ID
ISRCTN12277345
Official title
Group body psychotherapy for the treatment of somatoform disorder - a partly randomised-controlled feasibility study

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: ISRCTN12277345. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Not recruiting

Germany

Compensation and expense reimbursement have not been verified for this summary.

Registry details
Registry conditions (original wording)

Somatoform disorder (ICD−10 (F45.x) (compatible with diagnosis of somatic symptom disorder DSM-5 (300.82); Mental and Behavioural Disorders; Somatoform disorder

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Department of Psychosomatic Medicine and Psychotherapy, Klinikum rechts der Isar,, a pharmaceutical company.

Is this study still recruiting?

The registry lists this study as not recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me